Annual Operating Profit
$16.08 M
+$38.80 M+170.76%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual operating income is $16.08 million, with the most recent change of +$38.80 million (+170.76%) on December 31, 2023.
- During the last 3 years, CTNM annual operating profit has risen by +$44.72 million (+156.12%).
- CTNM annual operating profit is now at all-time high.
Performance
CTNM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$12.97 M
-$2.03 M-18.55%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly operating income is -$12.97 million, with the most recent change of -$2.03 million (-18.55%) on September 30, 2024.
- Over the past year, CTNM quarterly operating profit has dropped by -$3.30 million (-34.08%).
- CTNM quarterly operating profit is now -133.32% below its all-time high of $38.94 million, reached on June 1, 2023.
Performance
CTNM Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$43.52 M
-$4.91 M-12.70%
September 30, 2024
Summary
- As of February 7, 2025, CTNM TTM operating income is -$43.52 million, with the most recent change of -$4.91 million (-12.70%) on September 30, 2024.
- Over the past year, CTNM TTM operating profit has dropped by -$59.60 million (-370.72%).
- CTNM TTM operating profit is now -253.40% below its all-time high of $28.37 million, reached on June 1, 2023.
Performance
CTNM TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
CTNM Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +170.8% | -34.1% | -370.7% |
| 3 y3 years | +156.1% | -138.1% | -698.8% |
| 5 y5 years | +156.1% | -138.1% | -698.8% |
CTNM Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +156.1% | -133.3% | at low | -253.4% | at low |
| 5 y | 5-year | at high | +156.1% | -133.3% | at low | -253.4% | at low |
| alltime | all time | at high | +156.1% | -133.3% | at low | -253.4% | at low |
Contineum Therapeutics Class A Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$12.97 M(+18.5%) | -$43.52 M(+12.7%) |
| Jun 2024 | - | -$10.94 M(+10.2%) | -$38.62 M(-442.9%) |
| Mar 2024 | - | -$9.93 M(+2.6%) | $11.26 M(-29.9%) |
| Dec 2023 | $16.08 M | -$9.68 M(+19.9%) | $16.08 M(-20.8%) |
| Sep 2023 | - | -$8.07 M(-120.7%) | $20.30 M(-28.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $38.94 M(-861.2%) | $28.37 M(-368.6%) |
| Mar 2023 | - | -$5.12 M(-6.1%) | -$10.56 M(+93.9%) |
| Dec 2022 | -$22.72 M(-20.7%) | - | - |
| Dec 2022 | - | -$5.45 M | -$5.45 M |
| Dec 2021 | -$28.65 M | - | - |
FAQ
- What is Contineum Therapeutics Class A annual operating income?
- What is the all time high annual operating profit for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual operating profit year-on-year change?
- What is Contineum Therapeutics Class A quarterly operating income?
- What is the all time high quarterly operating profit for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly operating profit year-on-year change?
- What is Contineum Therapeutics Class A TTM operating income?
- What is the all time high TTM operating profit for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A TTM operating profit year-on-year change?
What is Contineum Therapeutics Class A annual operating income?
The current annual operating profit of CTNM is $16.08 M
What is the all time high annual operating profit for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual operating income is $16.08 M
What is Contineum Therapeutics Class A annual operating profit year-on-year change?
Over the past year, CTNM annual operating income has changed by +$38.80 M (+170.76%)
What is Contineum Therapeutics Class A quarterly operating income?
The current quarterly operating profit of CTNM is -$12.97 M
What is the all time high quarterly operating profit for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly operating income is $38.94 M
What is Contineum Therapeutics Class A quarterly operating profit year-on-year change?
Over the past year, CTNM quarterly operating income has changed by -$3.30 M (-34.08%)
What is Contineum Therapeutics Class A TTM operating income?
The current TTM operating profit of CTNM is -$43.52 M
What is the all time high TTM operating profit for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high TTM operating income is $28.37 M
What is Contineum Therapeutics Class A TTM operating profit year-on-year change?
Over the past year, CTNM TTM operating income has changed by -$59.60 M (-370.72%)